Skip to content
Tenfell
Awarded contract
Published 21 May 2018

NHS Framework Agreement - Hepatitis C Medicines

NHS England · London

Key facts

Awarded
15 Apr 2018
Contract starts
31 Mar 2018
Contract ends
31 Mar 2019
Procedure
Open procedure
Buyer type
Central government

Awarded to 4 suppliers

SupplierValue
Merck Sharp & Dohme UK Ltd—
Abbvie Ltd—
Gilead Sciences Limited—
Roche Products Ltd—

Description

NHS Framework Agreement for Hepatitis C medicines for Midlands & East and North of England regions and NHS Framework Agreement for Hepatitis C Medicines for London and South of England regions

Period of framework agreement: CM/PHR/17/5560/01 - Hepatitis C medicines for Midlands & East and North of England - 1 April 2018 - 28 March 2019 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

CM/PHR/17/5560/02 - Hepatitis C medicines for Midlands & East and North of England and Hepatitis C Medicines for London and South of England - 1 April 2018 - 28 March 2019 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

Additional information: Attached is the model form framework agreement. All of the awarded frameworks were made on the basis of the model form framework agreement. Redacted award schedules have been attached for each of the awarded suppliers.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.